SEC Form 4 · accession 0001140361-18-024271
aTYR PHARMA INC · LIFE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
EcoR1 Capital Fund Qualified, L.P.
10% Owner
Period of report
May 14, 2018
Accepted (ET)
May 16, 2018 · 5:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001339970
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 14, 2018 | S | 354,791 | $1.7167 | D | 2,854,525 | D | |
| Common Stock | May 15, 2018 | S | 121,294 | $1.4268 | D | 2,733,231 | D | |
| Common Stock | May 16, 2018 | S | 2,733,231 | $0.8111 | D | 0 | D |
Table II — derivative securities
No Table II lines on this filing.